HIGHLIGHTS
- who: Jeanne Bohler and colleagues from the Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland have published the article: Blinatumomab in Relapsed/Refractory Burkitt Lymphoma, in the Journal: Cancers 2023, 44 of /2023/
- what: The comparison of this quantitative data with the study is not appropriate due to the small number of patients in the study , but it can be compared qualitatively.
- future: Investigation should be made in combination with other treatments in the future by collaborative approaches with the aim of improving the outcomes of patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.